Top
Institution / University College Dublin
City scape

Biopharmaceutical Engineering

MEngSc Biopharmaceutical Engineering
This Masters provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry and offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Programme Outcomes
-Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
-Understand the engineering principles underlying the production of biopharmaceuticals
-Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
-Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production facility
-Demonstrate the ability to work as part of a design team for the development of a new production facility
-Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
-Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
-Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering

Vision & Values Statement
The MEngSc Biopharmaceutical Engineering programme provides intensive training in the requisite skills for a professional engineer or scientist in the biopharmaceutical or related sector. The programme provides substantial coverage of the scientific, technical, management and regulatory issues associated with this industry. The programme's teaching methods are highly interactive and varied and student learning is assessed using a variety of assessment methodology including exams, assignments, case studies and presentations. Students complete a research project which consolidates their basic knowledge of the course content and provides intensive research experience and training. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities. It is anticipated that graduates from this programme will play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.

Entry requirements

-An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account, so that in certain exceptional cases an award at a lower level or a 2.2 classification may be considered.
-Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.

Duration

1 year full time - T070
2 years part time - T015

Careers or further progression

Your career opportunities upon graduation from this programme are exemplary and the programme has an excellent employment record. This Masters results in an internationally recognised graduate qualification that provides graduates with the knowledge and skills required to gain high level professional jobs in the biopharmaceutical and pharmaceutical sector.

Ireland is a world player in pharmaceutical and biopharmaceutical production. The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of largest pharmaceutical and biopharmaceutical companies in the world including Pfizer, GSK, Merck, AbbVie, Novartis, Jansen Biologics (Ireland), Biomarin, Roche, Sanofi Genzyme and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

Further enquiries

Contact Name: Katie O'Neill
Contact Number: +353 (0)1 716 1781

Subjects taught

Stage 1 Core

Animal Cell Culture Technology CHEN40040

Bioreactor Modelling and Control CHEN40060

Bioprocessing Laboratory CHEN40090

Facility Design and Operation CHEN40110

Biopharmaceutical Industry Regulation and Management CHEN40120

Bioprocess Scale-up and Technology Transfer CHEN40130

Biopharmaceutical Engineering Project CHEN40140

Bioseparations CHEN40460

Lean Sigma Biopharma Process CHEN40480

Bioprocess Design CHEN40530

Regulatory Affairs in Science PHAR40240

Stage 1 - Option

Molecular Genetics and Biotech BMOL20090

Instrumental Analysis CHEM30110

Principles of Biopharmaceutical Engineering CHEN40020

Process Design, Safety and Economics CHEN40170

Comment

This programme is closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excelllence for training and research in bioprocessing. NIBRT offers a quality training and research experience not previously possible anywhere in the world. At the heart of the NIBRT building is the bioprocessing pilot plant, consisting of extensive upstream, downstream, fill-finish and the associated analytical facilities. These facilities are all operated in a realistic GMP simulated, operational manufacturing environment

Application date

The following entry routes are available:

MEngSc Biopharmaceutical Engineering FT (T070)
Duration 1 Years
Attendance Full Time
Deadline Rolling *

MEngSc Biopharmaceutical Engineering PT (T015)
Duration 2 Years
Attendance Part Time
Deadline Rolling *

* Courses will remain open until such time as all places have been filled, therefore early application is advised

Enrolment and start dates

Next Intake: 2018/2019 September

Remember to mention gradireland when contacting institutions!